Form 8-K - Current report:
SEC Accession No. 0001193125-25-155811
Filing Date
2025-07-07
Accepted
2025-07-07 07:15:14
Documents
12
Period of Report
2025-07-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d156610d8k.htm   iXBRL 8-K 34766
  Complete submission text file 0001193125-25-155811.txt   151112

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cogt-20250707.xsd EX-101.SCH 2855
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20250707_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20250707_pre.xml EX-101.PRE 11264
14 EXTRACTED XBRL INSTANCE DOCUMENT d156610d8k_htm.xml XML 3625
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 251106969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)